Published “Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer” in New England Journal of Medicine — cited 8,681 times.
- #crossref
- #research
- #work
← Calyampudi Radhakrishna Rao timeline
Published “Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer” in New England Journal of Medicine — cited 8,681 times.
Captured 2026-08-19 from Crossref. The archived copy is preserved so this citation survives link rot.